Why is prolonged-release tapentadol phosphate not recommended for patients with a history of seizures?

Prolonged-release tapentadol phosphate has not been systematically evaluated in patients with seizure disorders, who were excluded from clinical trials, and, like other mu-opioid agonist analgesics, is not recommended for those at seizure risk; it may also increase seizure risk with medicines that lower the seizure threshold.